Creso Pharma to be purchased for $122 million

Australian cannabis company Creso Pharma is to be purchased by Canadian-owned cannabis producer PharmaCielo for $122 million.

The ASX-listed company announced on Friday that it had entered into a scheme implementation agreement and advised that shareholders will receive the equivalent of 63 cents per share in PharmaCielo’s TSX Venture Exchange-listed stock, a 51.8 per cent premium.

PharmaCielo is a fully licensed producer of medicinal cannabis oil products in Colombia and plans to produce CBD and THC oil extracts later this year.

Creso Pharma co-founder and chief executive Miri Halperin Wernli said shareholders will benefit from being part of a “best in class and well-capitalised global medicinal cannabis company.”

“The combined companies will offer a unique combination of assets and professional skills across the cannabis value chain,” Wernli said.

In April Creso said it received firm commitments to raise $5.35 million via a series of secured loans, to support the sales and marketing of Creso’s human and animal health CBD-based products in Europe and Canada and to repay approximately $1 million in debt.

Comments

Comment Manually

I have read and agree to the Terms and Conditions and Privacy Policy.

Inside FMCG Jobs

Loading...

FMCG Products

Company:

Category:

View details

Latest Poll

Will your business be taking part in the climate strike this Friday?
x

SUBSCRIBE
FREE NEWS BRIEFS Get breaking news delivered